Angiotensin II production and distribution in the kidney – II

Slides:



Advertisements
Similar presentations
V.M. Campese, N. Mitra, D. Sandee  Kidney International 
Advertisements

Massive bleeding after biopsy of a renal allograft
Volume 70, Issue 10, Pages (November 2006)
Volume 68, Issue 2, Pages (August 2005)
Viper venom for diabetic nephropathy
Volume 80, Issue 6, Pages (September 2011)
Membranous nephropathy: When and how to treat
Viper venom for diabetic nephropathy
Expression and role of connexins in the rat renal vasculature
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Volume 61, Issue 6, Pages (June 2002)
Relaxin in cardiovascular and renal disease
Volume 68, Issue 3, Pages (September 2005)
The intrarenal renin-angiotensin system in hypertension
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Volume 63, Issue 3, Pages (March 2003)
Volume 59, Issue 4, Pages (April 2001)
Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy  S.C.W. Tang, J.C.K.
V.M. Campese, N. Mitra, D. Sandee  Kidney International 
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
How to interpret the eGFR in patients with small body surface area
A new era in phosphate binder therapy: What are the options?
Volume 63, Issue 2, Pages (February 2003)
Volume 70, Issue 4, Pages (August 2006)
Volume 70, Issue 11, Pages (December 2006)
G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali 
Volume 71, Issue 11, Pages (June 2007)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis  J. Mahmood, F. Khan, S. Okada,
Fructose intake as a risk factor for kidney stone disease
Volume 75, Issue 1, Pages (January 2009)
Volume 70, Issue 1, Pages (July 2006)
Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney 
Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells  Z. Su, J. Zimpelmann, K.D. Burns  Kidney.
The third World Kidney Day: Looking back and thinking forward
Impact of gender on the renal response to angiotensin II
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 85, Issue 5, Pages (May 2014)
Volume 65, Issue 6, Pages (June 2004)
Angiotensin II production and distribution in the kidney: I
Volume 69, Issue 10, Pages (May 2006)
Volume 59, Issue 5, Pages (May 2001)
Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats  Quaisar Ali,
Volume 68, Issue 4, Pages (October 2005)
Volume 71, Issue 4, Pages (February 2007)
Volume 57, Issue 2, Pages (October 2000)
Volume 69, Issue 7, Pages (April 2006)
Volume 73, Issue 3, Pages (February 2008)
Massive bleeding after biopsy of a renal allograft
Leptin and inflammation-associated cachexia in chronic kidney disease
Organ transplantation goes to the movies
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 69, Issue 3, Pages (February 2006)
Volume 68, Issue 5, Pages (November 2005)
A functional immature model of chronic partial ureteral obstruction1
Volume 80, Issue 10, Pages (November 2011)
Volume 69, Issue 10, Pages (May 2006)
Volume 70, Issue 3, Pages (August 2006)
Volume 72, Issue 6, Pages (September 2007)
Volume 70, Issue 5, Pages (September 2006)
Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease  A.R. Chade, D. Brosh, S.T.
Volume 66, Issue 4, Pages (October 2004)
T cells and T-cell receptors in acute renal failure
Rebound kinetics of β2-microglobulin after hemodialysis
Volume 65, Issue 6, Pages (June 2004)
Volume 61, Issue 4, Pages (April 2002)
Volume 70, Issue 1, Pages (July 2006)
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Angiotensin II production and distribution in the kidney – II Angiotensin II production and distribution in the kidney – II. Model-based analysis of experimental data  M.A.D.H. Schalekamp, A.H.J. Danser  Kidney International  Volume 69, Issue 9, Pages 1553-1557 (May 2006) DOI: 10.1038/sj.ki.5000305 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Bar graphs showing the ratio between the concentration of intrarenally produced Ang I in peritubular interstitial fluid and the plasma concentration of Ang I in the renal artery (CIiIsfPt/CIPa), and the ratio between the interstitial fluid concentration of intrarenally produced Ang II and the plasma concentration of Ang II in the renal artery (CIIiIsf/CIIiPa). Calculations were made using data obtained in anesthetized pigs2 and equations (22)–(24) in Schalekamp and Danser.1 CIaPv/CIPa in these equations is taken to be equal to 0.15, as measured in control animals (Table 1). Data refer to peritubular transcapillary diffusive Ang I and II clearance rates (ClDiffPt) of 0.1, 0.3, and 0.5 ml/min per gram of renal cortex.1 Open bars: control; hatched bars: captopril treatment; closed bars: eprosartan treatment. Kidney International 2006 69, 1553-1557DOI: (10.1038/sj.ki.5000305) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Effect of ACE inhibition by captopril on the ratio between the calculated concentration, in peritubular interstitial fluid, of intrarenally produced Ang II and the concentration of intrarenally produced Ang I. Calculations were made using data obtained in anesthetized pigs2 and equations (22)–(24) in Schalekamp and Danser.1*P<0.05 for differences from control animals and animals treated with the AT1 receptor antagonist eprosartan. Kidney International 2006 69, 1553-1557DOI: (10.1038/sj.ki.5000305) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Schematic presentation of concentrations of endocrine Ang II in tissue compartments of the renal cortex. Approximate values are presented, as calculated from data obtained in anesthetized pigs.2 Calculations are based on the kinetic model described in Schalekamp and Danser.1 Glomeruli are assumed to occupy 5% of the total volume of renal cortex.19 Kidney International 2006 69, 1553-1557DOI: (10.1038/sj.ki.5000305) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 Schematic representation of concentrations of paracrine Ang II in tissue compartments of the renal cortex. Approximate values are presented, as calculated from data obtained in anesthetized pigs.2 Calculations are based on the kinetic model described in Schalekamp and Danser.1*: at a peritubular transcapillary diffusive clearance rate of Ang II (ClDiffPt) of, respectively, 0.5–0.1 ml/min per gram of renal cortex.1 Kidney International 2006 69, 1553-1557DOI: (10.1038/sj.ki.5000305) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Line graphs showing the concentrations of cell surface AT1 receptors in glomerular and peritubular interstitial fluid (CAT1RCsGlom, CAT1RCsPt), the concentration of cell surface AT2 receptors in peritubular interstitial fluid (CAT2RCsPt), as a function of the peritubular transcapillary diffusive clearance rate of Ang II (ClDiffPt). The amount of arterially delivered Ang II in the glomerular region, expressed as a fraction of the total amount of arterially delivered Ang II in the renal cortex (CIIaGlom/CIIaT), is also shown. Calculations were made by using equations (48)–(53) in Schalekamp and Danser.1 Kidney International 2006 69, 1553-1557DOI: (10.1038/sj.ki.5000305) Copyright © 2006 International Society of Nephrology Terms and Conditions